High Sensitivity Troponin I: What We Should Know?

Cardiac troponins are the preferred biomarkers for diagnosing Acute Myocardial Infarction(AMI). In patients with Acute Coronary Syndrome, increased levels of cTns are associated with increased risk of death and re-admissions, and identify patients who benefit from early, intensified treatment. In pa...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of clinical biochemistry Vol. 32; no. S1; p. S17
Main Author Sickan, Jaganathan
Format Journal Article
LanguageEnglish
Published Springer 24.05.2022
Subjects
Cardiac patients
Care and treatment
Heart attack
Mortality
Prognosis
Online AccessGet full text

Cover

More Information
Summary:Cardiac troponins are the preferred biomarkers for diagnosing Acute Myocardial Infarction(AMI). In patients with Acute Coronary Syndrome, increased levels of cTns are associated with increased risk of death and re-admissions, and identify patients who benefit from early, intensified treatment. In patients with stable Coronary Artery Disease(CAD), cTn measured by a high sensitive assay is detectable in the large majority of patients. Interestingly, even levels below the 99th percentile of a healthy reference population provide prognostic information, and predict risk of mortality and development of Heart Failure, and in AMI.
ISSN:0970-1915
0974-0422